Skip to main content

Table 2 Clinical data after 12 ± 2 months of optimized therapy

From: Cost of persistent asthma in Italy

 

Overall cohort

Group A

FEV1 ≥ 80%

Group B

FEV1 < 80 ≥ 60%

Group C

FEV1 < 60%

n

817

508

202

107

FEV1%

93.79 (±0.70)

103.92 (±0.60)

83.92 (±1.00)

64.34 (±1.73)

Relapses, n,a

0.45 (±0.03)

0.31 (±0.03)

0.62 (±0.08)

0.79 (±0.12)

  1. Mean (±SE, standard error)
  2. FEV1%: forced expiratory volume in 1 s, predicted values
  3. aRelapses with and without hospitalization
Back to article page

Multidisciplinary Respiratory Medicine

ISSN: 2049-6958

Contact us